News

US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need
US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need - FDA approval paves the way for the ...
The BMJ22m
“Hard to justify” $28 000 price tag for breakthrough HIV prevention treatment, says UN agency
A United Nations agency has urged the pharmaceutical company Gilead Sciences to lower the price of the long acting antiviral treatment lenacapavir following the US Food and Drug Administration (FDA)’s ...
The American Journal of Managed Care20h
Lenacapavir Offers Promising Step Forward in HIV Prevention: Q&A With Onyema Ogbuagu, MBBCh, FACP, FIDSA
The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...
Managed Healthcare Executive11h
With Lenacapavir 'You've Basically Got a Vaccine.' But Reaching the People Who Would Benefit Is Difficult, Says Gates Foundation Expert
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Harvard Medical School1d
2025 Warren Alpert Prize Honors Scientists Whose Discoveries Culminated in Novel HIV Treatment
The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...